Stay updated with breaking news from David Sallman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Andrew Kuykendall, MD, discusses the current role of JAK inhibitors in myelofibrosis, the importance of chronic graft-vs-host disease awareness in patients with myeloid malignancies receiving transplant, and unmet needs for patients with chronic myelomonocytic leukemia.
/PRNewswire/ -- Syntrix Pharmaceuticals today announced results from a single-arm, open-label Phase 1 trial of single-agent SX-682, an investigational CXCR1/2...
Gilead and Kite Oncology to present latest blood cancer research at the European Hematology Association (EHA) 2022 CongressSub-analyses from Kite’s ZUMA-7 study of CAR T cell therapy in second-line diffuse large B cell lymphoma includes data in patients over 65 and by tumour burden characteristicsLonger-term d...
'It's of paramount importance that we do better for these patients,' expert notes
Transforming the Field of Hematopoietic Stem Cell Therapies Nasdaq: JSPR April 28th, 2022 Safe Harbor Forward-Looking... | April 28, 2022